12 results on '"Bourboulia, Dimitra"'
Search Results
2. Decrypting the chaperone code.
- Author
-
Truman, Andrew W., Bourboulia, Dimitra, and Mollapour, Mehdi
- Subjects
- *
SCIENTIFIC ability , *GTPASE-activating protein , *HEAT shock factors , *RAS proteins , *ALLOSTERIC regulation , *MUTANT proteins , *HEAT shock proteins , *MOLECULAR chaperones - Published
- 2021
- Full Text
- View/download PDF
3. Extracellular HSP90 warms up integrins for an irisin workout.
- Author
-
Bourboulia, Dimitra, Woodford, Mark R., and Mollapour, Mehdi
- Abstract
The hormone-like protein irisin is involved in browning of adipose tissue and regulation of metabolism. Recently, Mu et al. identified the extracellular chaperone heat shock protein-90 (Hsp90) as the activating factor for "opening" αVβ5 integrin receptor, allowing for high-affinity irisin binding and effective signal transduction. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Activation of autophagy depends on Atg1/Ulk1-mediated phosphorylation and inhibition of the Hsp90 chaperone machinery.
- Author
-
Backe, Sarah J., Sager, Rebecca A., Heritz, Jennifer A., Wengert, Laura A., Meluni, Katherine A., Aran-Guiu, Xavier, Panaretou, Barry, Woodford, Mark R., Prodromou, Chrisostomos, Bourboulia, Dimitra, and Mollapour, Mehdi
- Abstract
Cellular homeostasis relies on both the chaperoning of proteins and the intracellular degradation system that delivers cytoplasmic constituents to the lysosome, a process known as autophagy. The crosstalk between these processes and their underlying regulatory mechanisms is poorly understood. Here, we show that the molecular chaperone heat shock protein 90 (Hsp90) forms a complex with the autophagy-initiating kinase Atg1 (yeast)/Ulk1 (mammalian), which suppresses its kinase activity. Conversely, environmental cues lead to Atg1/Ulk1-mediated phosphorylation of a conserved serine in the amino domain of Hsp90, inhibiting its ATPase activity and altering the chaperone dynamics. These events impact a conformotypic peptide adjacent to the activation and catalytic loop of Atg1/Ulk1. Finally, Atg1/Ulk1-mediated phosphorylation of Hsp90 leads to dissociation of the Hsp90:Atg1/Ulk1 complex and activation of Atg1/Ulk1, which is essential for initiation of autophagy. Our work indicates a reciprocal regulatory mechanism between the chaperone Hsp90 and the autophagy kinase Atg1/Ulk1 and consequent maintenance of cellular proteostasis. [Display omitted] • Autophagy-initiating kinase Atg1/Ulk1 phosphorylates a conserved serine in Hsp90 • Atg1/Ulk1-mediated phosphorylation of Hsp90 is essential for autophagy induction • Hsp90 phosphorylation by Atg1/Ulk1 regulates client protein activity • Phosphorylation of Hsp90 is essential for Atg1 conformational change and activity Backe et al. show a reciprocal regulatory mechanism between the chaperone Hsp90 and the autophagy kinase client Atg1/Ulk1. This consequently leads to maintenance of cellular proteostasis and activation of autophagy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer.
- Author
-
Dushukyan, Natela, Dunn, Diana M., Sager, Rebecca A., Woodford, Mark R., Loiselle, David R., Daneshvar, Michael, Baker-Williams, Alexander J., Chisholm, John D., Truman, Andrew W., Vaughan, Cara K., Haystead, Timothy A., Bratslavsky, Gennady, Bourboulia, Dimitra, and Mollapour, Mehdi
- Abstract
The serine/threonine protein phosphatase 5 (PP5) regulates multiple cellular signaling networks. A number of cellular factors, including heat shock protein 90 (Hsp90), promote the activation of PP5. However, it is unclear whether post-translational modifications also influence PP5 phosphatase activity. Here, we show an "on/off switch" mechanism for PP5 regulation. The casein kinase 1d (CK1d) phosphorylates T362 in the catalytic domain of PP5, which activates and enhances phosphatase activity independent of Hsp90. Overexpression of the phosphomimetic T362E-PP5 mutant hyper-dephosphorylates substrates such as the co-chaperone Cdc37 and glucocorticoid receptor in cells. Our proteomic approach revealed that the tumor suppressor von Hippel-Lindau protein (VHL) interacts with and ubiquitinates K185/K199-PP5 for proteasomal degradation in a hypoxia- and prolyl-hydroxylation-independent manner. Finally, VHL-deficient clear cell renal cell carcinoma (ccRCC) cell lines and patient tumors exhibit elevated PP5 levels. Downregulation of PP5 causes ccRCC cells to undergo apoptosis, suggesting a prosurvival role for PP5 in kidney cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. PhosY-secretome profiling combined with kinase-substrate interaction screening defines active c-Src-driven extracellular signaling.
- Author
-
Backe, Sarah J., Votra, SarahBeth D., Stokes, Matthew P., Sebestyén, Endre, Castelli, Matteo, Torielli, Luca, Colombo, Giorgio, Woodford, Mark R., Mollapour, Mehdi, and Bourboulia, Dimitra
- Abstract
c-Src tyrosine kinase is a renowned key intracellular signaling molecule and a potential target for cancer therapy. Secreted c-Src is a recent observation, but how it contributes to extracellular phosphorylation remains elusive. Using a series of domain deletion mutants, we show that the N-proximal region of c-Src is essential for its secretion. The tissue inhibitor of metalloproteinases 2 (TIMP2) is an extracellular substrate of c-Src. Limited proteolysis-coupled mass spectrometry and mutagenesis studies verify that the Src homology 3 (SH3) domain of c-Src and the P
31 VHP34 motif of TIMP2 are critical for their interaction. Comparative phosphoproteomic analyses identify an enrichment of PxxP motifs in phosY-containing secretomes from c-Src-expressing cells with cancer-promoting roles. Inhibition of extracellular c-Src using custom SH3-targeting antibodies disrupt kinase-substrate complexes and inhibit cancer cell proliferation. These findings point toward an intricate role for c-Src in generating phosphosecretomes, which will likely influence cell-cell communication, particularly in c-Src-overexpressing cancers. [Display omitted] • Deletion of the SH4/unique domain impairs c-Src secretion • Identification of critical c-Src:TIMP2 protein interaction interfaces • c-Src phosY secretome is enriched with PxxP-containing targets • c-Src antibodies block secreted kinase-substrate interactions and tumor cell growth Backe et al. use biochemical, phosphoproteomic, and cell-based approaches to investigate c-Src kinase secretion and its interaction with extracellular substrate TIMP2 and to characterize the nature of c-Src-expressing phosY secretomes. c-Src antibodies interfere with kinase-substrate interactions, extracellular tyrosine phosphorylation, and cellular function, providing the basis to develop alternative therapeutic strategies for c-Src-overexpressing cancers. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
7. A specialized Hsp90 co-chaperone network regulates steroid hormone receptor response to ligand.
- Author
-
Backe, Sarah J., Sager, Rebecca A., Regan, Bethany R., Sit, Julian, Major, Lauren A., Bratslavsky, Gennady, Woodford, Mark R., Bourboulia, Dimitra, and Mollapour, Mehdi
- Abstract
Heat shock protein-90 (Hsp90) chaperone machinery is involved in the stability and activity of its client proteins. The chaperone function of Hsp90 is regulated by co-chaperones and post-translational modifications. Although structural evidence exists for Hsp90 interaction with clients, our understanding of the impact of Hsp90 chaperone function toward client activity in cells remains elusive. Here, we dissect the impact of recently identified higher eukaryotic co-chaperones, FNIP1/2 (FNIPs) and Tsc1, toward Hsp90 client activity. Our data show that Tsc1 and FNIP2 form mutually exclusive complexes with FNIP1, and that unlike Tsc1, FNIP1/2 interact with the catalytic residue of Hsp90. Functionally, these co-chaperone complexes increase the affinity of the steroid hormone receptors glucocorticoid receptor and estrogen receptor to their ligands in vivo. We provide a model for the responsiveness of the steroid hormone receptor activation upon ligand binding as a consequence of their association with specific Hsp90:co-chaperone subpopulations. [Display omitted] • FNIP1 forms mutually exclusive functional complexes with FNIP2 and Tsc1 co-chaperones • Hsp90 co-chaperone complexes differentially regulate client protein activity • FNIP1/2 and Tsc1 enhance steroid hormone receptor ligand binding and activity • Hsp90 induces structural changes in the glucocorticoid receptor ligand-binding pocket Backe et al. demonstrate that responsiveness of the steroid hormone receptors upon ligand-binding-mediated activation depends on their association with specific Hsp90:co-chaperone (FNIP1, FNIP2, and Tsc1) subpopulations. This study reveals that formation of different Hsp90:co-chaperone:client complexes provide differentially primed pools of client proteins ready to act in different cellular environments. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis.
- Author
-
Baker-Williams, Alexander J., Hashmi, Fiza, Budzyński, Marek A., Woodford, Mark R., Gleicher, Stephanie, Himanen, Samu V., Makedon, Alan M., Friedman, Derek, Cortes, Stephanie, Namek, Sara, Stetler-Stevenson, William G., Bratslavsky, Gennady, Bah, Alaji, Mollapour, Mehdi, Sistonen, Lea, and Bourboulia, Dimitra
- Abstract
The extracellular molecular chaperone heat shock protein 90 (eHSP90) stabilizes protease client the matrix metalloproteinase 2 (MMP2), leading to tumor cell invasion. Although co-chaperones are critical modulators of intracellular HSP90:client function, how the eHSP90:MMP2 complex is regulated remains speculative. Here, we report that the tissue inhibitor of metalloproteinases-2 (TIMP2) is a stress-inducible extracellular co-chaperone that binds to eHSP90, increases eHSP90 binding to ATP, and inhibits its ATPase activity. In addition to disrupting the eHSP90:MMP2 complex and terminally inactivating MMP2, TIMP2 loads the client to eHSP90, keeping the protease in a transient inhibitory state. Secreted activating co-chaperone AHA1 displaces TIMP2 from the complex, providing a "reactivating" mechanism for MMP2. Gene knockout or blocking antibodies targeting TIMP2 and AHA1 released by HT1080 cancer cells modify their gelatinolytic activity. Our data suggest that TIMP2 and AHA1 co-chaperones function as a molecular switch that determines the inhibition and reactivation of the eHSP90 client protein MMP2. • Stress-inducible TIMP2 is a bona fide co-chaperone of extracellular HSP90 (eHSP90) • TIMP2 regulates HSP90 chaperone function and interaction with client MMP2 • Secreted co-chaperones TIMP2 and AHA1 displace each other on the eHSP90:MMP2 complex • TIMP2-AHA1 competition impacts client MMP2 activity and matrix gelatinolysis Hundreds of intracellular proteins depend on molecular chaperone heat shock protein 90 (HSP90) and its co-chaperones to properly function. Baker-Williams et al. identify two secreted co-chaperones that act as a molecular switch to inhibit and reactivate extracellular HSP90 (eHSP90) client matrix metalloproteinase 2 (MMP2). This mechanism impacts matrix degradation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90.
- Author
-
Sager, Rebecca A., Woodford, Mark R., Backe, Sarah J., Makedon, Alan M., Baker-Williams, Alexander J., DiGregorio, Bryanna T., Loiselle, David R., Haystead, Timothy A., Zachara, Natasha E., Prodromou, Chrisostomos, Bourboulia, Dimitra, Schmidt, Laura S., Linehan, W. Marston, Bratslavsky, Gennady, and Mollapour, Mehdi
- Abstract
Summary The molecular chaperone Hsp90 stabilizes and activates client proteins. Co-chaperones and post-translational modifications tightly regulate Hsp90 function and consequently lead to activation of clients. However, it is unclear whether this process occurs abruptly or gradually in the cellular context. We show that casein kinase-2 phosphorylation of the co-chaperone folliculin-interacting protein 1 (FNIP1) on priming serine-938 and subsequent relay phosphorylation on serine-939, 941, 946, and 948 promotes its gradual interaction with Hsp90. This leads to incremental inhibition of Hsp90 ATPase activity and gradual activation of both kinase and non-kinase clients. We further demonstrate that serine/threonine protein phosphatase 5 (PP5) dephosphorylates FNIP1, allowing the addition of O -GlcNAc (O -linked N-acetylglucosamine) to the priming serine-938. This process antagonizes phosphorylation of FNIP1, preventing its interaction with Hsp90, and consequently promotes FNIP1 lysine-1119 ubiquitination and proteasomal degradation. These findings provide a mechanism for gradual activation of the client proteins through intricate crosstalk of post-translational modifications of the co-chaperone FNIP1. Graphical Abstract Highlights • Casein-kinase-2-mediated sequential phosphorylation of the co-chaperone FNIP1 • FNIP1 relay phosphorylation leads to gradual activation of Hsp90 clients • Serine/threonine protein phosphatase 5 (PP5) dephosphorylates FNIP1 • O -GlcNAcylation causes ubiquitination and proteasomal degradation of FNIP1 Sager et al. show that casein-kinase-2-mediated sequential phosphorylation of the co-chaperone FNIP1 leads to incremental inhibition of Hsp90 ATPase activity and gradual activation of both kinase and non-kinase clients. O -GlcNAcylation antagonizes phosphorylation of FNIP1, preventing its interaction with Hsp90, and consequently promotes FNIP1 ubiquitination and proteasomal degradation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. The Role of Heat Shock Protein-90 in the Pathogenesis of Birt-Hogg-Dubé and Tuberous Sclerosis Complex Syndromes.
- Author
-
Woodford, Mark R, Backe, Sarah J, Sager, Rebecca A, Bourboulia, Dimitra, Bratslavsky, Gennady, and Mollapour, Mehdi
- Subjects
- *
TUBEROUS sclerosis , *KIDNEY tumors , *RENAL cell carcinoma , *MOLECULAR chaperones , *SYNDROMES , *ANGIOMYOLIPOMA - Abstract
Birt-Hogg-Dubé (BHD) and tuberous sclerosis (TS) syndromes share many clinical features. These two diseases display distinct histologic subtypes of renal tumors: chromophobe renal cell carcinoma and renal angiomyolipoma, respectively. Early work suggested a role for mTOR dysregulation in the pathogenesis of these two diseases, however their detailed molecular link remains elusive. Interestingly, a growing number of case reports describe renal angiomyolipoma in BHD patients, suggesting a common molecular origin. The BHD-associated proteins FNIP1/2 and the TS protein Tsc1 were recently identified as regulators of the molecular chaperone Hsp90. Dysregulation of Hsp90 activity has previously been reported to support tumorigenesis, providing a potential explanation for the overlapping phenotypic manifestations in these two hereditary syndromes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer.
- Author
-
Hashmi, Fiza, Mollapour, Mehdi, Bratslavsky, Gennady, and Bourboulia, Dimitra
- Subjects
- *
PROTEIN-tyrosine kinases , *RENAL cancer , *EXTRACELLULAR matrix , *MATRIX metalloproteinases , *PROTEOLYSIS , *PROTEOLYTIC enzymes , *RENAL cell carcinoma , *METABOLISM , *CELLULAR signal transduction , *KIDNEY tumors , *EXTRACELLULAR space - Abstract
Patients diagnosed with metastatic renal cell carcinoma (RCC) have ∼12% chance for 5-year survival. The integrity of the extracellular matrix (ECM) that surrounds tumor cells influences their behavior and, when disturbed, it could facilitate local invasion and spread of tumor cells to distant sites. The interplay between von Hippel-Lindau/hypoxia inducible factor signaling axis and activated kinase networks results in aberrant ECM and tumor progression. Matrix metalloproteinases (MMPs) are proteolytic enzymes implicated in ECM remodeling, tumor angiogenesis, and immune cell infiltration. Understanding the cross-talk between kinase signaling and ECM proteolysis in RCC could provide insights into developing drugs that interfere specifically with the process of invasion. In this review, we discuss changes in the MMPs/ECM axis in RCC, prominent kinase signaling pathways implicated in MMPs induction, and comment on emerging extracellular regulatory networks that modulate MMPs activity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma.
- Author
-
Bratslavsky, Gennady, Gleicher, Stephanie, Jacob, Joseph M., Sanford, Thomas H., Shapiro, Oleg, Bourboulia, Dimitra, Gay, Laurie M, Andrea Elvin, Julie, Vergilio, Jo-Anne, Suh, James, Ramkissoon, Shakti, Severson, Eric Allan, Killian, Jonathan Keith, Schrock, Alexa Betzig, Chung, Jon H., Miller, Vincent A., Mollapour, Mehdi, and Ross, Jeffrey S.
- Subjects
- *
RENAL cell carcinoma , *MEDULLARY thyroid carcinoma , *PROTEIN-tyrosine kinases , *CARCINOMA , *EPIDERMAL growth factor receptors , *METASTASIS , *CANCER cells , *GENETIC mutation , *GENE expression profiling , *KIDNEY tumors , *GENOMICS - Abstract
Introduction and Objective: Unlike clear cell renal cell carcinoma (CCRCC), collecting duct carcinoma (CDC) and renal medullary carcinoma (RMC) are rare tumors that progress rapidly and appear resistant to current systemic therapies. We queried comprehensive genomic profiling to uncover opportunities for targeted therapy and immunotherapy.Material and Methods: DNA was extracted from 40 microns of formalin-fixed, paraffin-embedded specimen from relapsed, mCDC (n = 46), mRMC (n = 24), and refractory and metastatic (m) mCCRCC (n = 626). Comprehensive genomic profiling was performed, and Tumor mutational burden (TMB) and microsatellite instability (MSI) were calculated. We analyzed all classes of genomic alterations.Results: mCDC had 1.7 versus 2.7 genomic alterations/tumor in mCCRCC ( = 0.04). Mutations in VHL (P < 0.0001) and TSC1 (P = 0.04) were more frequent in mCCRCC. SMARCB1 (P < 0.0001), NF2 (P = 0.0007), RB1 (P = 0.02) and RET (P = 0.0003) alterations were more frequent in mCDC versus mCCRCC. No VHL alterations in mRMC and mCDC were identified. SMARCB1 genomic alterations were significantly more frequent in mRMC than mCDC (P = 0.0002), but were the most common alterations in both subtypes. Mutations to EGFR, RET, NF2, and TSC2 were more frequently identified in mCDC versus mRMC. The median TMB and MSI-High status was low with <1% of mCCRC, mCDC, and mRMC having ≥ 20 mut/Mb.Conclusion: Genomic alteration patterns in mCDC and mRMC differ significantly from mCCRCC. Targeted therapies for mCDC and mRMC appear limited with rare opportunities to target alterations in receptor tyrosine kinase and MTOR pathways. Similarly, TMB and absence of MSI-High status in mCDC and mRMC suggest resistance to immunotherapies. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.